D-0689-2021 Class III Terminated
FDA drug recall D-0689-2021 was initiated by Teligent Pharma, Inc. on June 22, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated July 3, 2024). Affected quantity: 7872 tubes.
Recall Details
- Product Type
- Drugs
- Report Date
- July 28, 2021
- Initiation Date
- June 22, 2021
- Termination Date
- July 3, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7872 tubes
Product Description
Erythromycin Topical Solution USP, 2% 60 mL, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310, NDC 52565-027-59
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide
Code Information
Lot 14180